Versiti, a national leader in blood health innovation, has announced the acquisition of Pearl Pathways, a recognized, trusted advisor and preferred partner for enabling innovative and expedited life science product development. Based in Indianapolis, Pearl Pathways is a full-service life science consulting firm, providing regulatory affairs, quality compliance, and niche CRO services. Pearl also has an independent, AHRPP accredited IRB supporting all aspects of human research. The organization supports biopharmaceutical, medical device, and diagnostic companies, as well as life science service providers with comprehensive clinical, regulatory, and quality compliance needs.
Read the full article: Versiti Acquires Indianapolis-Based Pearl Pathways //